[Home ] [Archive]    
:: Main :: About :: Current Issue :: Archive :: Search :: Submit ::
:: Volume 31, Issue 1 (1-2019) ::
J Islam Dent Assoc Iran 2019, 31(1): 26-32 Back to browse issues page
Decreased Salivary Cortisol in Recurrent Aphthous Stomatitis Treat-ed with Topical Steroids
Hendri Susanto 1, Puout Kendarwati2, Kholifastia Imanusti2, Laxmi Widyanigsih2, Sri Budiarti3, A Supriatno3
1- Department of Oral Medicine, Faculty of Dentistry, Universitas Gadjah Mada, Yogyakarta, Indonesia , drghendri@ugm.ac.id
2- Dental Study Program, Faculty of Dentistry, Universitas Gadjah Mada, Yogyakarta, Indonesia
3- Department of Oral Medicine, Faculty of Dentistry, Universitas Gadjah Mada, Yogyakarta, Indonesia
Abstract:   (756 Views)
Background and Aim: Stress has been associated with recurrent aphthous stomatitis (RAS). The common treatment of RAS is a topical steroid. This study aimed to investigate the difference of salivary cortisol between RAS patients treated with a topi-cal steroid and those without treatment.
Materials and Methods: Thirty-two female patients with RAS participated in this case-control study and were randomly divided into two groups: the case group (n=16) treated with a topical steroid and the control group (n=16) without any treatment. The inclusion criteria comprised of non-pregnant women with RAS. The exclusion criteria consisted of having other diseases, taking medications, and smoking. All subjects were examined for pre- and post-treatment salivary cortisol at the onset of the ulcers in the case group and when the ulcers were healed in the control group. Data on the characteristics of the subjects were collected and presented descriptively, and the difference in salivary cortisol was analyzed using Mann-Whitney-U test and independ-ent t-test with a 95% confidence interval (CI) in SPSS 17.00 software.
Results: The mean salivary cortisol in the pre-treatment group (10.51±5.15 ng/ml) was higher than that in the post-treatment group (9.30±3.77 ng/ml). The mean salivary cortisol at the onset of RAS (9.55±4.03 ng/ml) was lower than when RAS was healed (13.07±3.82 ng/ml) in the control group. There was a significant difference in the mean of pre- and post-treatment salivary cortisol levels between the case and the control groups (P<0.05).
Conclusion: Topical steroids may not only reduce inflammation of oral ulcers but also may reduce salivary cortisol in RAS.
Keywords: Recurrent Aphthous Stomatitis, Saliva, Cortisol, Topical Steroid
Full-Text [PDF 331 kb]   (173 Downloads)    
Type of Study: Orginal | Subject: Oral Medicine
1. Natah SS, Konttinen YT, Enattah NS, Ashanmakhi N, Sharkey KA, Hayrinen-Immonen R. Recurrent aphthous ulcers today: a review of the growing knowledge. Int J Oral Maxillofac Surg. 2004 Apr;33(3):221-34.
2. Abdullah MJ. Prevalence of recurrent aphthous ulceration experience in patients attending Piramird dental speciality in Sulaimani City. J Clin Exp Dent. 2013 Apr;5(2):e89-e94.
3. Patil S, Reddy SN, Maheshwari S, Khandelwal S, Shruthi D, Doni B. Prevalence of recurrent aphthous ulceration in the Indian Population. J Clin Exp Dent. 2014 Feb 1;6(1):e36-40.
4. Erman MK, Rosenberg R. Modafinil for excessive sleepiness associated with chronic shift work sleep disorder: Effects on patient functioning and health-related quality of life. Prim Care Companion J Clin Psychiatry. 2007;9(3):188-194.
5. Ślebioda Z, Szponar E, Kowalska A. Etiopathogenesis of recurrent aphthous stomati-tis and the role of immunologic aspects: litera-ture review. Arch Immunol Ther Exp (Warsz). 2014 Jun;62(3):205-15.
6. Challacombe SJ, Alsahaf S, Tappuni A. Recurrent Aphthous Stomatitis: Towards Evidence-Based Treatment ? Curr Oral Health Rep. 2015 Sep;2(3):158-67.
7. Preeti L, Magesh K., Rajkumar K, Karthik R. Recurrent aphthous stomatitis. J Oral Maxillofac Pathol. 2011 Sep;15(3):252-6.
8. Safadi RA. Prevalence of recurrent aphthous ulceration in Jordanian dental patients. BMC Oral Health. 2009 Nov;9:31.
9. Scully C, Porter S. Oral mucosal disease: recurrent aphthous stomatitis. Br J Oral Maxillo-fac Surg. 2008 Apr;46(3):198-206.
10. Phillips LJ, McGorry PD, Garner B, Thompson KN, Pantelis C, Wood SJ, et al. Stress, the hippocampus and the hypothalamic-pituitary-adrenal axis: implications for the development of psychotic disorders. Aust N Z J Psychiatry. 2006 Sep;40(9):725-41.
11. Elenkov IJ. Glucocorticoids and the Th1/Th2 balance. Ann N Y Acad Sci. 2004 Jun;1024:138-46.
12. Quijano D, Rodríguez M. [Topical corticosteroids in recurrent aphthous stomatitis. Systematic review]. [Article in Spanish]. Acta Otorrinolaringol Esp. 2008 Jun-Jul;59(6):298-307.
13. Taylor J, Brocklehurst P, Glenny A, Walsh T, Tickle M, Lewis MA, et al. Topical interven-tions for recurrent aphthous stomatitis (mouth ulcers). Cochrane Database Syst Rev. 2013 Dec;12: CD010881.
14. Al-Omiri MK, Karasneh J, Alhijawi MM, Zwiri AM, Scully C, Lynch E. Recurrent aphthous stomatitis (RAS): a preliminary within-subject study of quality of life, oral health impacts and personality profiles. J Oral Pathol Med. 2015 Apr; 44(4):278-83.
15. Nadendla LK, Meduri V, Paramkusam G, Pachava KR. Relationship of salivary cortisol and anxiety in recurrent aphthous stomatitis. Indian J Endocrinol Metab. 2015 Jan-Feb;19(1):56-9.
16. Rezaei F, Aminian M, Raygani AV. Evaluation of Salivary Cortisol Changes and Psychological Profiles in Patients with Recurrent Aphthous Stomatitis. Contemp Clin Dent. 2017 Apr-Jun; 8 (2):259-263.
17. Bilal N, Fatih Karakus M, Varkal MD, Boztepe OF, Bilal B, Sarica S. An Assessment of the Levels of Anxiety and Depression in Patients with Recurrent Aphthous Stomatitis. Arch Otolaryn-gol Rahinol. 2016 Jan;2(1):1-5.
18. Kunikullaya UK, Kumar MA, Ananthakrishnan V, Jaisri G. Stress as a cause of recurrent aphthous stomatitis and its correla-tion with salivary stress markers. Chin J Physiol. 2017 Aug 31;60(4):226-30.
19. Dorn LD, Lucke JF, Loucks TL, Berga SL. Sali-vary cortisol reflects serum cortisol: analysis of circadian profiles. Ann Clin Biochem. 2007 May; 44(Pt 3):281-4.
20. Tappuni AR, Kovacevic T, Shirlaw PJ, Challacombe SJ. Clinical assessment of disease severity in recurrent aphthous stomatitis. J Oral Pathol Med. 2013 Sep;42(8):635-41.
21. Jurge S, Kuffer R, Scully C, Porter SR. Mucosal dis-ease series. Number VI. Recurrent aphthous stomatitis. Oral Dis. 2006 Jan;12(1):1-21.
22. Guo S, Dipietro LA. Factors affecting wound healing. J Dent Res. 2010 Mar;89(3):219-29.
23. Albanidou-Farmaki E, Poulopoulos AK, Epivatianos A, Farmakis K, Karamouzis M, Antoniades D. Increased anxiety level and high salivary and serum cortisol concentrations in patients with recurrent aphthous stomatitis. Tohoku J Exp Med. 2008 Apr;214(4):291-6.
24. Liu YZ, Wang YX, Jiang CL. Inflammation: The Common Pathway of Stress-Related Dis-eases. Front Hum Neurosci. 2017 Jun 20;11:316.
25. Hoyer J, Burmann I, Kieseler ML, Vollrath F, Hellrung L, Arelin K, et al. Menstrual cycle phase modulates emotional conflict processing in women with and without premenstrual syn-drome (PMS)--a pilot study. PLoS One. 2013 Apr 24;8(4):e59780.
26. Rao AK, Vundavalli S, Sirisha NR, Jayasree CH, Sindhura G, Radhika D. The association between psychological stress and recurrent aphthous stomatitis among medical and dental student cohorts in an educational setup in India. J Indian Assoc Public Health Dent. 2015 Jun; 13(2): 133-37.
27. Das A. Psychosocial distress and inflammation: Which way does causality flow? Soc Sci Med. 2016 Dec;170:1-8.
28. Khammissa RAG, Ballyram R, Wood NH, Lemmer J, Feller L. Glucocorticosteroids in the treatment of immune mediated oral diseases. S Afr Dent J. 2016 Mar;71(2):62-7.
29. Savage NW, McCullough MJ. Topical corticosteroids in dental practice. Aust Dent J. 2005 Dec;50(4 Suppl 2):S40-4.
30. Cruz-Topete D, Cidlowski JA. One hormone, two actions: anti- and pro-inflammatory effects of glucocorticoids. Neuroimmunomodulation. 2015; 22(1-2):20-32.
31. Fantuzzi G, Ghezzi P. Glucocorticoids as cytokine inhibitors: role in neuroendocrine con-trol and therapy of inflammatory diseases. Me-diators Inflamm. 1993;2(4):263-70.
32. Iwata M, Ota KT, Duman RS. The inflammasome: pathways linking psychological stress, depression, and systemic illnesses. Brain Behav Immun. 2013 Jul;31:105-14.
Send email to the article author

Add your comments about this article
Your username or Email:


XML     Print

Download citation:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:

Susanto H, Kendarwati P, Imanusti K, Widyanigsih L, Budiarti S, Supriatno A. Decreased Salivary Cortisol in Recurrent Aphthous Stomatitis Treat-ed with Topical Steroids . J Islam Dent Assoc Iran. 2019; 31 (1) :26-32
URL: http://jidai.ir/article-1-2004-en.html

Volume 31, Issue 1 (1-2019) Back to browse issues page
Journal of Islamic Dental Association of Iran


This work is licensed under a Creative Commons Attribution-NonCommercial 3.0 Unported License which allows users to read, copy, distribute and make derivative works for non-commercial purposes from the material, as long as the author of the original work is cited properly

Persian site map - English site map - Created in 0.05 seconds with 31 queries by YEKTAWEB 4030